About

Catherine T. Haring is a rising surgical oncologist and researcher whose work centers on the treatment and outcomes of oropharyngeal squamous cell carcinoma (OPSCC), particularly in the context of transoral robotic surgery (TORS). Her research addresses critical gaps in head and neck cancer care, from postoperative quality metrics to the role of emerging technologies in patient education. In her highly cited 2023 study on national readmission trends following TORS, Haring demonstrated that readmission can delay adjuvant therapy and compromise survival—a finding with direct implications for perioperative protocols. She has also pioneered the evaluation of artificial intelligence in oncology, authoring a 2024 study assessing ChatGPT’s accuracy in answering common patient questions about HPV-positive oropharyngeal carcinoma, which has garnered significant attention for its relevance to modern clinical communication. Her 2025 work on referral patterns further illuminates disparities in oropharyngeal cancer management. With over 18 citations across her most impactful papers, Haring is establishing herself as a thoughtful voice at the intersection of surgical oncology, health services research, and digital health innovation.

Research Focus

Key Achievements

2
H-Index
3
Papers
18
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
National Trends in 30-Day Readmission Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
11 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago